Approximately 35 million individuals are currently living with HIV/AIDS.
Benefit structure and formulary design characteristics are important for individuals with high out-of-pocket costs in federally facilitated Health Insurance Exchanges.
In September 2009, the Pharmacy & Therapeutics Society gathered a study group of 12 managed care medical and pharmacy directors. The objective was to examine the impact that biomarker-based assays could have on the approaches payers and providers use to manage cancer.
Pharmacists should encourage patients to recognize and report any symptoms of depression in order to achieve optimal control of diabetes.
We assessed time to maintenance dose attainment in commercially insured men initiating topical testosterone agents and compared daily maintenance doses and costs of this therapy.
Inhibiting the calcium release-activated calcium channel found to be an effective approach to limit allergic asthma without affecting the body’s defenses against influenza.
A CMS guide to the new medicare part D overutilization policies has takeaways for pharmacists.
Pharmacists can serve as essential members of a research team in a role that involves much more than traditional dispensing functions.
Pharmacists should identify barriers that may prevent patients from adhering to complicated regimens or receiving proper care.
Effective clinical programs in specialty pharmacy encourage adherence and lead to superior treatment outcomes.
The number of patients who have from diabetes is expected to almost double from 285 million to 438 million people by 2030 due to obesity trends.
Individuals working in a health care field are often expected to have up-to-date information about the latest trends in laws and legislative changes related to their specialty.
The American Diabetes Association recommends that health care providers incorporate an estimated average glucose measurement when counseling patients with diabetes.
The study found no mean difference in all-cause healthcare costs for patients with newly diagnosed nonvalvular atrial fibrillation initiating treatment with dabigatran versus warfarin.
This medication list helps screen for and assess potentially inappropriate drugs to prevent adverse effects, hospitalization, and even death.
Methotrexate >15 mg weekly and adalimumab as first-line therapy were positive predictors of anti-TNF-a response in patients with rheumatoid arthritis.
Pharmacists were inducted into the world of immunizations about 20 years ago when they were first authorized to administer vaccines, making immunizations more accessible.
This study reports on barriers to and facilitators of medication adherence for asthma and diabetes patients who were both adherent and nonadherent to their medication regimen.
The contributions to patient care through the incorporation of digital clinical pharmacotherapy will help legitimize the role of pharmacists in telehealth.
The panel of pneumococcal vaccination experts offer their concluding insights and perspectives on the current landscape of pneumococcal vaccines.
An examination of payer coverage for multiple sclerosis drugs shows variation in how these drugs are covered and in the evidence that payers review to make these decisions.
The 340B Drug Pricing Program requires covered entities to ensure program integrity through several processes.
Healthcare is transforming through new payment models, including value-based incentives (VBIs); this article discusses implementation principles and operational strategies for VBIs in community pharmacy practice.